Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2022-02-18 00:00:00 ET · period of report 2022-02-16 · accession 0000899243-22-007020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-18 | 2022-02-16 | MYGN | DIAZ PAUL J | Pres, CEO, Dir | A - Grant | $0.00 | +234.3K | 1.03M | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-16 | A | A | 234,271 | $0.00 | 1,030,369 | D | — | — |